+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Dengue Vaccine Market 2021-2025

  • PDF Icon

    Report

  • May 2021
  • Region: Global
  • TechNavio
  • ID: 5349656
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the dengue vaccine market and it is poised to grow by 132.90 million during 2021-2025, progressing at a CAGR of about 18% during the forecast period. This report on the dengue vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rapid growth in disease prevalence and ineffective dengue control measures. In addition, rapid growth in disease prevalence is anticipated to boost the growth of the market as well.

The dengue vaccine market analysis includes the end-user segment and geographic landscape.

The dengue vaccine market is segmented as below:

By End-user
  • Government institutions
  • Hospitals
  • NGOs

By Geographical Landscape
  • North America
  • Asia
  • Europe
  • ROW

This study identifies the initiatives for dengue vaccine research and dengue immunization programs as one of the prime reasons driving the dengue vaccine market growth during the next few years.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

This report on dengue vaccine market covers the following areas:
  • Dengue vaccine market sizing
  • Dengue vaccine market forecast
  • Dengue vaccine market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dengue vaccine market vendors that include BioNet-Asia Co. Ltd., Chula VRC, Codagenix Inc., GeneOne Life Science Inc., Imutex Ltd., KM Biologics Co. Ltd., Medigen Biotechnology Corp., Najít Technologies Inc., Sanofi SA, and Emergex Vaccines Holding Ltd. Also, the dengue vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user
  • Market segments
  • Comparison by End-user
  • Government institutions - Market size and forecast 2020-2025
  • Hospitals - Market size and forecast 2020-2025
  • NGOs - Market size and forecast 2020-2025
  • Market opportunity by End-user

Customer Landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Vendor landscape
  • Competitive Scenario
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • BioNet-Asia Co. Ltd.
  • Chula VRC
  • Codagenix Inc.
  • Emergex Vaccines Holding Ltd.
  • GeneOne Life Science Inc.
  • Imutex Ltd.
  • KM Biologics Co. Ltd.
  • Medigen Biotechnology Corp.
  • Najít Technologies Inc.
  • Sanofi SA

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • End user - Market share 2020-2025 (%)
  • Comparison by End user
  • Government institutions - Market size and forecast 2020-2025 ($ million)
  • Government institutions - Year-over-year growth 2020-2025 (%)
  • Hospitals - Market size and forecast 2020-2025 ($ million)
  • Hospitals - Year-over-year growth 2020-2025 (%)
  • NGOs - Market size and forecast 2020-2025 ($ million)
  • NGOs - Year-over-year growth 2020-2025 (%)
  • Market opportunity by End user
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • BioNet-Asia Co. Ltd. - Overview
  • BioNet-Asia Co. Ltd. - Product and service
  • BioNet-Asia Co. Ltd. - Key offerings
  • BioNet-Asia Co. Ltd. - Key customers
  • BioNet-Asia Co. Ltd. - Segment focus
  • Chula VRC - Overview
  • Chula VRC - Product and service
  • Chula VRC - Key offerings
  • Chula VRC - Key customers
  • Chula VRC - Segment focus
  • Codagenix Inc. - Overview
  • Codagenix Inc. - Product and service
  • Codagenix Inc. - Key offerings
  • Codagenix Inc. - Key customers
  • Codagenix Inc. - Segment focus
  • Emergex Vaccines Holding Ltd. - Overview
  • Emergex Vaccines Holding Ltd. - Product and service
  • Emergex Vaccines Holding Ltd. - Key offerings
  • Emergex Vaccines Holding Ltd. - Key customers
  • Emergex Vaccines Holding Ltd. - Segment focus
  • GeneOne Life Science Inc. - Overview
  • GeneOne Life Science Inc. - Product and service
  • GeneOne Life Science Inc. - Key offerings
  • GeneOne Life Science Inc. - Key customers
  • GeneOne Life Science Inc. - Segment focus
  • Imutex Ltd. - Overview
  • Imutex Ltd. - Product and service
  • Imutex Ltd. - Key offerings
  • Imutex Ltd. - Key customers
  • Imutex Ltd. - Segment focus
  • KM Biologics Co. Ltd. - Overview
  • KM Biologics Co. Ltd. - Product and service
  • KM Biologics Co. Ltd. - Key offerings
  • KM Biologics Co. Ltd. - Key customers
  • KM Biologics Co. Ltd. - Segment focus
  • Medigen Biotechnology Corp. - Overview
  • Medigen Biotechnology Corp. - Product and service
  • Medigen Biotechnology Corp. - Key offerings
  • Medigen Biotechnology Corp. - Key customers
  • Medigen Biotechnology Corp. - Segment focus
  • Najít Technologies Inc. - Overview
  • Najít Technologies Inc. - Product and service
  • Najít Technologies Inc. - Key offerings
  • Najít Technologies Inc. - Key customers
  • Najít Technologies Inc. - Segment focus
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key offerings
  • Sanofi SA - Key customers
  • Sanofi SA - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global dengue vaccine market: BioNet-Asia Co. Ltd., Chula VRC, Codagenix Inc., GeneOne Life Science Inc., Imutex Ltd., KM Biologics Co. Ltd., Medigen Biotechnology Corp., Najít Technologies Inc., Sanofi SA, and Emergex Vaccines Holding Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is initiatives for dengue vaccine research and dengue immunization programs.'

According to the report, one of the major drivers for this market is the rapid growth in disease prevalence.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BioNet-Asia Co. Ltd.
  • Chula VRC
  • Codagenix Inc.
  • GeneOne Life Science Inc.
  • Imutex Ltd.
  • KM Biologics Co. Ltd.
  • Medigen Biotechnology Corp.
  • Najít Technologies Inc.
  • Sanofi SA
  • Emergex Vaccines Holding Ltd.